BL
BIVV

Balentine LLC’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Balentine LLC’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-320
Closed -$17K – 621
2017
Q4 		$17K Hold
320
– – ﹤0.01% 409
2017
Q3 		$18K Buy
320
+69
+27% +$4.04K ﹤0.01% 400
2017
Q2 		$15K Hold
251
– – ﹤0.01% 410
2017
Q1 		$14K Buy
+251
New +$12.4K ﹤0.01% 391

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Balentine LLC's BIVV Position: Q1 2018 in Review

Balentine LLC sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 320 shares — an estimated $17K sold.

Balentine LLC first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $18K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Balentine LLC reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Balentine LLC sold 320 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $17K.
  • Balentine LLC first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Balentine LLC's Bioverativ Inc. Common Stock position peaked at $18K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Balentine LLC's 13F filing for Q1 2018, filed 16 May 2018.